Q1 2026 Rainbow Children's Medicare Ltd Earnings Call Transcript

Jul 30, 2026 / 04:30 AM GMT

Release Date Price: ₹1525 (+0.59%)

Transcript

Key Points

Positve

Rainbow Childrens Medicare Ltd (BOM:543524) delivered robust revenue growth of approximately 33% year-on-year, driven by balanced contributions from mature hospitals and new facilities.
The company maintained a healthy EBITDA margin of 28.6% despite initial operating losses at newly commissioned hospitals, demonstrating operational resilience and disciplined cost management.
Expansion strategy is gaining momentum with a definitive agreement for a 100-bed hospital in Malad, Mumbai, marking entry into Western India, and acquisitions in Andhra Pradesh to strengthen its presence.
The company has a strong balance sheet with cash equivalents and investments of Rs. 613 crores, providing financial stability to fund its ambitious expansion plan of adding 2,500 beds over the next five years.
Management expressed confidence in sustaining a revenue growth rate of around 20% in the medium term, with a target to double the top-line in four years, supported by strong operating metrics like a 6% improvement in RPOB.

Negative

Profit after tax (PAT) growth of 16% year-on-year lagged behind revenue growth, indicating margin pressure from new hospital ramp-ups and integration costs.
Newer hospitals, such as the Electronic City facility in Bangalore, are still incurring losses and are expected to take 12-18 months to break even, which could continue to weigh on overall profitability.
The company faces challenges in entering new geographic markets, including the need to build a clinical ecosystem and brand trust, which requires significant time and investment.
Management acknowledged potential margin pressure due to the significant bed capacity added in the last two years, with EBITDA margins expected to remain in the 24-25% range for the year.
The company's expansion into high-cost markets like Mumbai and Delhi NCR carries risks related to higher operational costs and the need to recruit and retain top clinical talent in competitive environments.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RAIB.NS - Rainbow Children's Medicare Ltd
Q1 2026 Rainbow Children's Medicare Ltd Earnings Call
Jul 31, 2026 / 04:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and Gentlemen, good day and welcome to Rainbow Children's Medicare Limited Q1 FY27 Earnings Conference Call hosted by IIFL Capital.

As a reminder, all participant lines will be the listen-only more and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touchstone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Rahul Jeevan from IIFL Capital.

Thank you and over to you, Mr. Jeevan.

--------------------------------------------------------------------------------
Unidentified_2

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.